Lamin A/C inhibitors belong to a class of compounds that specifically target the lamin A and lamin C proteins, which are integral components of the nuclear lamina-a network of intermediate filaments that provides structural support to the cell nucleus. These inhibitors function by disrupting the normal processing and post-translational modifications of lamin A and lamin C, ultimately leading to alterations in the nuclear lamina's structure and organization. This class of inhibitors primarily works by interfering with the farnesylation process of lamin A, a lipid modification that is essential for its proper localization and function within the nuclear envelope. By inhibiting farnesylation, these compounds impede the attachment of lipid moieties to the proteins, resulting in mislocalization and altered interactions with other nuclear components.
In addition to their impact on protein localization, lamin A/C inhibitors can also influence nuclear morphology. The disruption of lamin A and lamin C processing can lead to irregularities in the nuclear shape and overall structure, which in turn may affect various cellular processes such as chromatin organization and gene expression. Furthermore, the altered nuclear architecture resulting from the use of these inhibitors might also impact mechanical properties of the cell, influencing its response to mechanical stress and strain. Research into the mechanisms of lamin A/C inhibitors is ongoing, as scientists seek to understand the intricate details of how these compounds interact with the nuclear lamina and influence cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $69.00 $162.00 $787.00 | 2 | |
While primarily known as a cholesterol-lowering drug, pravastatin has also shown potential as a lamin A/C inhibitor. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin has been regularly investigated for its inhibitory effects on lamin A/C processing in a laboratory setting. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
This compound interferes with the farnesylation process, thereby impacting lamin A/C localization and function. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
A specific FTI that has been studied for its potential to target lamin A/C and improve symptoms in certain genetic disorders like progeria. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Like other statins, atorvastatin has been explored for its effects on lamin A/C processing and nuclear envelope integrity. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
This compound has shown some potential in inhibiting lamin A/C-related processes. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Another statin that has been investigated for its impact on lamin A/C and related cellular functions. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
A geranylgeranyltransferase inhibitor that can disrupt the prenylation of lamin A, affecting its localization. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that has been explored for its impact on nuclear envelope stability and potential effects on lamin A/C. | ||||||